Authors: van der Kolk, DM de Vries, EGE Noordhoek, L van den Berg, E van der Pol, MA Muller, M Vellenga, E

Citation: Dm. Van Der Kolk et al., Activity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in de novo and relapsed acute myeloid leukemia, LEUKEMIA, 15(10), 2001, pp. 1544-1553

Authors: van der Kolk, DM de Vries, EGE Vellenga, E

Citation: Dm. Van Der Kolk et al., Deletion of the multidrug resistance protein 1 (MRP1) gene in acute myeloid leukemia patients with inversion 16: expression of MRP1 homologues, LEUKEMIA, 15(1), 2001, pp. 191-192

Authors: van der Kolk, DM de Vries, EGE van Putten, WLJ Verdonck, LF Ossenkoppele, GJ Verhoef, GEG Vellenga, E

Citation: Dm. Van Der Kolk et al., P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia, CLIN CANC R, 6(8), 2000, pp. 3205-3214

Authors: Scheffer, GL Maliepaard, M Pijnenborg, ACLM van Gastelen, MA de Jong, MC Schroeijers, AB van der Kolk, DM Allen, JD Ross, DD van der Valk, P Dalton, WS Schellens, JHM Scheper, RJ

Citation: Gl. Scheffer et al., Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines, CANCER RES, 60(10), 2000, pp. 2589-2593

Authors: van der Kolk, DM Vellenga, E van der Veen, AY Noordhoek, L Timmer-Bosscha, H Ossenkoppele, GJ Raymakers, RA Muller, M van den Berg, E de Vries, EGE

Citation: Dm. Van Der Kolk et al., Deletion of the multidrug resistance protein MRP1 gene in acute myeloid leukemia: the impact on MRP activity, BLOOD, 95(11), 2000, pp. 3514-3519